Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barre and Fisher's syndromes

Journal of Neuroimmunology

Volumn 81, Issue 1-2, 1998, Pages 138-143

  Koga, Michiaki ^a,b   Yuki, Nobuhiro ^a   Takahashi, Masaki ^c   Saito, Kahiko ^c   Hirata, Koichi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Anti ganglioside antibody; Campylobacter jejuni; Fisher's syndrome; Gulllain Barre syndrome; IgA

Indexed keywords

GANGLIOSIDE ANTIBODY; IMMUNOGLOBULIN A;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CAMPYLOBACTER JEJUNI; DISEASE ASSOCIATION; GRAM NEGATIVE INFECTION; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SERODIAGNOSIS; SUBCLAVIAN STEAL SYNDROME;

EID: 0031862942     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00168-9     Document Type: Article

References (26)

1. Asbury A.K., Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 27(suppl):1990;S21-S24.
2. Blaser M.J., Duncan D.J. Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay. Infect. Immun. 44:1984;292-298.
3. Chiba A., Kusunoki S., Shimizu T., Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann. Neurol. 31:1992;677-679.
4. Enders U., Karch H., Toyka K.V., Michels M., Zielasek J., Pette M., Heesemann J., Hartung H.P. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann. Neurol. 34:1993;136-144.
5. Herbrink P., van den Munckhof H.A.M., Bumkens M., Lindeman J., van Dijk W.C. Human serum antibody response in Campylobacter jejuni enteritis as measured by enzyme-linked immunosorbent assay. Eur. J. Clin. Microbiol. Infect. Dis. 7:1988;388-393.
6. Ilyas A.A., Mithen F.A., Chen Z.W., Cook S.D. Anti-GM1 IgA antibodies in Guillain-Barré syndrome. J. Neuroimmunol. 36:1992;69-76.
7. Jacobs B.C., van Doorn P.A., Schmitz P.I.M., Tio-Gillen A.P., Herbrink P., Visser L.H., Hooijkaas H., van der Meché F.G.A. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Ann. Neurol. 40:1996;181-187.
8. Kaldor J., Pritchard H., Serpell A., Metcalf W. Serum antibodies in Campylobacter enteritis. J. Clin. Microbiol. 18:1983;1-4.
9. Kaldor J., Speed B.R. Guillain-Barré syndrome and Campylobacter jejuni [sic]: a serological study. BMJ. 288:1984;1867-1870.
10. Kuroki S., Saida T., Nukina M., Haruta T., Yoshioka M., Kobayashi Y., Nakanishi H. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-N-acetylglucosamine residues. Ann. Neurol. 33:1993;243-247.
11. McCoy E.C., Doyle D., Burda L., Corbeil L.B., Winter A.J. Superficial antigens of Campylobacter (Vibrio) fetus: Characterization of an antiphagocytic component. Infect. Immun. 11:1975;517-525.
12. Mestecky J., McGhee J.R. Immunoglobulin A (IgA): Molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol. 40:1987;153-245.
13. Mishu B., Ilyas A.A., Koski C.L., Vriesendorp F., Cook S.D., Mithen F.A., Blaser M.J. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann. Intern. Med. 118:1993;947-953.
14. Rees J.H., Soudain S.E., Gregson N.A., Hughes R.A.C. Campylobacter jejuni infection and Guillain-Barré syndrome. N. Engl. J. Med. 333:1995;1374-1379.
15. Rees J.H., Gregson N.A., Hughes R.A.C. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann. Neurol. 38:1995;809-816.
16. Roberts T., Shah A., Graham J.G., McQueen I. The Miller Fisher syndrome following Campylobacter [sic] enteritis: a report of two cases. J. Neurol. Neurosurg. Psychiatry. 50:1987;1557-1558.
17. Ropper, A.H., Wijdicks, E.F.M., Truax, B.T., 1991. Guillain-Barré syndrome. F.A. Davis, Philadelphia, PA, pp. 18-21.
18. Speed B.R., Kaldor J., Watson J., Newton-John H., Tee W., Noonan D., Dwyer B.W. Campylobacter jejuni/Campylobacter coli-associated Guillain-Barré syndrome. Immunoblot confirmation of the serological response. Med. J. Aust. 147:1987;13-16.
19. van den Berg L.H., Marrink J., de Jager A.E.J., de Jong H.J., van Imhoff G.W., Latov N., Sadiq S.A. Anti-GM1 antibodies in patients with Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry. 55:1992;8-11.
20. Dutch Guillain-Barré study group, Visser L.H., van der Meché F.G.A., van Doorn P.A., Meulstee J., Jacobs B.C., Oomes P.G., Kleyweg R.P. Guillain-Barré syndrome without sensory loss (acute motor neuropathy): A subgroup with specific clinical, electrodiagnostic and laboratory features. Brain. 118:1995;841-847.
21. Willison H.J., Veitch J., Paterson G., Kennedy P.G.E. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J. Neurol. Neurosurg. Psychiat. 56:1993;204-206.
22. Wroe S.J., Blumhardt L.D. Acute polyneuritis with cranial nerve involvement following Campylobacter jejuni [sic] infection. J. Neurol. Neurosurg. Psychiatry. 48:1985;593.
23. Yuki N., Taki T., Inagaki F., Kasama T., Takahashi M., Saito K., Handa S., Miyatake T. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 178:1993;1771-1775.
24. Yuki N., Sato S., Tsuji S., Hozumi I., Miyatake T. An immunological abnormality common to Bickerstaff's brain stem encephalitis and Fisher's syndrome. J. Neurol. Sci. 118:1993;83-87.
25. Yuki N., Sato S., Tsuji S., Ohsawa T., Miyatake T. Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology. 43:1993;414-417.
26. Yuki N., Ichikawa H., Doi A. Fisher syndrome after Campylobacter jejuni enteritis: Human leukocyte antigen and the bacterial serotype. J. Pediatr. 126:1995;55-57.